This inventor holds 1 USPTO granted patent. Top assignee: Oxford University Innovation Ltd. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: Katherine Wright: Innovator in Malaria Treatment
Introduction
Katherine Wright is a notable inventor based in Oxford, GB. She has made significant contributions to the field of medical research, particularly in the treatment and prevention of malaria. Her innovative work has the potential to impact global health positively.
Latest Patents
Katherine holds a patent related to the treatment and prevention of malaria. The patent includes antigens, vectors encoding the antigens, and antibodies, along with other binding compounds to the antigens. These components are utilized in the prevention or treatment of malaria. Specifically, her invention provides fragments of Reticulocyte-binding protein Homologue 5 (PfRH5), which are rationally designed based on the PfRH5 crystal structure. The fragments are designed to lack disordered regions, particularly the flexible N-terminal region and/or flexible central linker.
Career Highlights
Katherine is associated with Oxford University Innovation Ltd, where she continues her research and development efforts. Her work is crucial in advancing the understanding and treatment of malaria, a disease that affects millions worldwide.
Collaborations
Katherine has collaborated with notable colleagues, including Alexander Douglas and Simon Draper. Their combined expertise enhances the research and development of innovative solutions in the field of malaria treatment.
Conclusion
Katherine Wright's contributions to malaria treatment through her innovative patent demonstrate her commitment to improving global health. Her work, along with her collaborations, positions her as a key figure in the fight against malaria.